US2018258131A1PendingUtilityA1

Nucleosides with antiviral and anticancer activity

Assignee: UNIV MINNESOTAPriority: Dec 9, 2004Filed: Oct 18, 2017Published: Sep 13, 2018
Est. expiryDec 9, 2024(expired)· nominal 20-yr term from priority
A61P 31/12A61P 35/00A61P 31/14C07F 9/6561C07H 19/19C07H 19/20C07H 19/052C07H 19/167C07H 19/16C07H 19/207C07K 4/00C07H 1/00C07F 9/65616C07H 19/10A61P 1/16C07H 19/23C07K 2/00
63
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

wherein R1-R6 and X have any of the values described herein, as well as pharmaceutical compositions comprising such compounds and therapeutic methods comprising the administration of such compounds.

Claims

exact text as granted — not AI-modified
1 . (canceled) 
     
     
         2 . A compound of formula:
 or a pharmaceutically acceptable salt thereof.

Join the waitlist — get patent alerts

Track US2018258131A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.